Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2021
Title: Innovations of Jean-Patrick Joly in Cancer Treatment
Introduction
Jean-Patrick Joly is a notable inventor based in Marseilles, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer and neurodegenerative disorders. His innovative work has led to the development of a unique patent that addresses critical health challenges.
Latest Patents
Jean-Patrick Joly holds a patent for "Proteasome inhibiting β-lactam prodrugs useful for the treatment of cancer and neurodegenerative disorders." This invention relates to proteasome inhibiting β-lactam compounds that are beneficial in treating these serious conditions. The patent also encompasses pharmaceutical compositions and extended release formulations of these compounds, along with their medical applications.
Career Highlights
Throughout his career, Jean-Patrick Joly has worked with various companies, including Philippe Yves-Rémy Simon and Vita Api. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Some of his notable coworkers include Philippe Yves-Rémy Simon and Henri Oreal. Their collaboration has likely played a role in advancing the research and development of innovative treatments.
Conclusion
Jean-Patrick Joly's contributions to the field of pharmaceuticals, particularly through his patent on proteasome inhibiting compounds, highlight his commitment to addressing critical health issues. His work continues to inspire advancements in cancer treatment and neurodegenerative disorder therapies.